Cort Breuer

Ph.D. Student in Immunology, admitted Autumn 2022

Bio

Cort Breuer is currently an Immunology PhD student in the lab of Nathan Reticker-Flynn. Cort received his BS in Biological Engineering from Cornell University in 2022, where he studied lymphatic-cancer interactions and T cell mechanosensing in the lab of Esak Lee. Previously, he worked with James Moon at Massachusetts General Hospital to develop in vivo gene therapies for the immune system and with Michelle Krogsgaard at NYU Perlmutter Cancer Center to investigate structural biology of TCR signaling. Cort’s current work focuses on mechanisms of tumor-immune tolerance and decoding the antigen specificity of T cell receptors. Drawing on his engineering background, he designs new molecular tools to record how immune cells communicate and constructs therapeutics to target impaired immune responses.

Honors & Awards

Graduate Fellow, Arc Institute (2022-2026)

Education & Certifications

BS, Cornell University College of Engineering, Biological Engineering (2022)

Lab Affiliations

Nathan Reticker-Flynn, Reticker-Flynn Lab (6/1/2023)

All Publications

Profiles With Related Publications

close
Anais Amaya

Postdoctoral Scholar, Stem Cell Transplantation

16 Total Publications
close
Jamie Bergen

Senior Web Developer, Law Communications

16 Total Publications
close
Helen M. Blau

Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Research Interests
Prof. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

304 Total Publications
close
Michele Calos

Professor of Genetics, Emerita
Research Interests
My lab is developing innovative gene and stem cell therapies for genetic diseases, with a focus on gene therapy and regenerative medicine.

We have created novel methods for inserting therapeutic genes into the chromosomes at specific places by using homologous recombination and recombinase enzymes.

We are working on 3 forms of muscular dystrophy.

We created induced pluripotent stem cells from patient fibroblasts, added therapeutic genes, differentiated, and engrafted the cells.

134 Total Publications
close
Pasqualina Colella

Senior Research Scientist, Pediatrics - Genetics

31 Total Publications
close
Le Cong

Assistant Professor of Pathology (Pathology Research) and of Genetics
Research Interests
Our lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene&cell therapy. We also leverages these gene-editing tools for single-cell functional screening, to probe molecular mechanisms of cancer and immunological diseases. To accelerate our work, we integrate AI and machine learning to design and evolve gene-editing proteins/RNAs in silico, pushing the frontier that bridges computational and experimental biology.

43 Total Publications
close
Drew Endy

Associate Professor of Bioengineering and Senior Fellow, by courtesy, at the Hoover Institution and at the Freeman Spogli Institute for International Studies

70 Total Publications
close
Stephen E. Harris

Kenneth and Barbara Oshman Professor in the School of Engineering and Professor of Applied Physics, Emeritus

158 Total Publications
close
Ioannis Karakikes

Associate Professor (Research) of Cardiothoracic Surgery
Research Interests
The Karakikes Lab aims to uncover fundamental new insights into the molecular mechanisms and functional consequences of pathogenic mutations associated with familial cardiovascular diseases.

79 Total Publications
close
Mark A. Kay, M.D., Ph.D.

Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Research Interests
Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

462 Total Publications
close
M. Peter Marinkovich, MD

Associate Professor of Dermatology
Clinical Focus
Cancer > Cutaneous (Dermatologic) Oncology, Epidermolysis Bullosa, Autoimmune Blistering Diseases, Pemphigus, Pemphigoid, Linear IgA Disease, Dermatitis Herpetiformis, Herpes Gestations, Dermatology
Research Interests
The Marinkovich lab studies the function of epithelial extracellular matrix molecules, including integrins, collagens and laminins in epithelial development and carcinoma progression. We apply our discoveries in this area towards development of molecular therapies for carcinomas, hair disease and inherited epithelial adhesive disorders.

263 Total Publications
close
Garry Nolan

Rachford and Carlota Harris Professor
Research Interests
Dr. Nolan's group uses high throughput single cell analysis technology cellular biochemistry to study autoimmunity, cancer, virology (influenza & Ebola), as well as understanding normal immune system function. Using advanced flow cytometric techniques such as Mass Cytometry, MIBI (ion beam imaging), CODEX and computational biology approaches, we focus on understanding disease processes at the single cell level. We have a strong interest in cancer immunotherapy and pathogen-host interactions.

466 Total Publications